Teriparatide biosimilar (Beijing Bokangjian Gene)
特立帕肽生物类似药（北京博康健基因）
Report date: 2025/12/12 16:28:56
Base Information
Drug NameTeriparatide biosimilar (Beijing Bokangjian Gene)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date2024/01/16
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBeijing Genetech Pharmaceutical Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesBeijing Genetech Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A